CymaBay Therapeutics

YTD

ALL

Why Robinhood?

You can watch CBAY and buy or sell other stocks, ETFs, and their options commission-free!

About CBAY

CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families.

CEO

Andrew D. Dickinson

CEOAndrew D. Dickinson

Employees

—

Employees—

Headquarters

Newark, California

HeadquartersNewark, California

Founded

1988

Founded1988

Employees

—

Employees—

CBAY Key Statistics

Market cap

3.73B

Market cap3.73B

Price-Earnings ratio

-32.75

Price-Earnings ratio-32.75

Dividend yield

—

Dividend yield—

Average volume

1.85M

Average volume1.85M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$32.50

52 Week high$32.50

52 Week low

$7.26

52 Week low$7.26